Summary
NicOx SA (NicOx) is an pharmaceutical company that develops ophthalmic portfolio of therapies and diagnostic tools. The company offers ophthalmic products which include AdenoPlus, AzaSite, BromSite, Xailin, Vesneo, next generation NO-donors and Syk and JAK inhibitors, and others. It offers products in the therapeutic areas of NO-donating compounds, based on a strong research platform which creates new molecular entities. NicOx operates research centers in Italy that works on R&D studies covering various therapy areas such as cardiovascular, inflammation and ophthalmology. The company operates in Germany, the UK, France, Italy and the US. NicOx is headquartered in Nice, France.
NicOx SA (COX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
NicOx SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
NicOx SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
NicOx SA, Medical Devices Deals, 2011 to YTD 2017 10
NicOx SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
NicOx SA, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
NicOx Acquires Carragelose from Marinomed Biotech for USD6.9 Million 12
Venture Financing 13
Aciex Therapeutics Raises US$1.6 Million In Venture Financing 13
Private Equity 14
GHO Capital Partners Acquires European and International Commercial Operations of Nicox 14
Partnerships 16
Nicox Exercises Option Agreement with Bausch & Lomb to Co-Promote Latanoprostene Bunod 16
Nicox Expands Co-Marketing Agreement with Immco Diagnostics for Sjo 17
Nicox Enters into Co-Marketing Agreement with Immco Diagnostics for Sjo 18
NicOx Enters Into Co-Marketing Agreement With European Pharma Company For Eye Care Products 19
Aciex Amends Research Agreement With Portola Pharma 20
NicOx Enters Into Option Agreement With Ferrer Internacional 21
Licensing Agreements 22
Akorn Enters Into Licensing Agreement With Aciex Therapeutics 22
Ora Enters into Licensing Agreement with Nicox Ophthalmics 23
Fera Pharma Enters into Licensing Agreement with Nicox 24
Santen Extends Licensing Agreement with Eupharmed to Distribute Cationorm 25
Equity Offering 26
NicOx Raises USD31 Million in Private Placement of Shares 26
Nicox to Raise USD20 Million in Private Placement of Shares 27
Nicox to Raise USD29.8 Million in Private Placement of Shares 28
Acquisition 29
Valeant Pharma Acquires Nicox for USD20 Million 29
NicOx Acquires Aciex Therapeutics 30
NicOx Acquires Doliage for USD6.5 Million 31
NicOx Completes Acquisition Of Eupharmed For US$8 Million 32
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 34
Akorn To Acquire Minority Stake In Aciex Therapeutics 36
NicOx SA - Key Competitors 37
NicOx SA - Key Employees 38
NicOx SA - Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Apr 27, 2017: Nicox first quarter 2017 business update and cash position 40
Mar 31, 2017: Nicox: Business Update and 2016 Financial Results 41
Sep 22, 2016: Nicox first half 2016 business and financial update 43
May 10, 2016: Nicox first quarter 2016 financial and business update 44
Apr 15, 2016: Nicox: 2015 Financial Results and Business Update 45
Feb 25, 2016: Nicox reports strong revenue growth in 2015 and provides corporate update 47
Corporate Communications 48
May 17, 2017: Mrs. Lauren P. Silvernail appointed to Nicox Board of Directors 48
May 17, 2017: Ms. Lauren P. Silvernail appointed to Nicox Board of Directors 49
Clinical Trials 50
Jan 05, 2017: Nicox provides clinical and regulatory update for NCX 4251 in blepharitis 50
Other Significant Developments 51
Oct 11, 2016: Nicox third quarter 2016 business update and cash position 51
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
List of Tables
NicOx SA, Pharmaceuticals & Healthcare, Key Facts, 2016 2
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
NicOx SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
NicOx SA, Deals By Therapy Area, 2011 to YTD 2017 9
NicOx SA, Medical Devices Deals, 2011 to YTD 2017 10
NicOx SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
NicOx Acquires Carragelose from Marinomed Biotech for USD6.9 Million 12
Aciex Therapeutics Raises US$1.6 Million In Venture Financing 13
GHO Capital Partners Acquires European and International Commercial Operations of Nicox 14
Nicox Exercises Option Agreement with Bausch & Lomb to Co-Promote Latanoprostene Bunod 16
Nicox Expands Co-Marketing Agreement with Immco Diagnostics for Sjo 17
Nicox Enters into Co-Marketing Agreement with Immco Diagnostics for Sjo 18
NicOx Enters Into Co-Marketing Agreement With European Pharma Company For Eye Care Products 19
Aciex Amends Research Agreement With Portola Pharma 20
NicOx Enters Into Option Agreement With Ferrer Internacional 21
Akorn Enters Into Licensing Agreement With Aciex Therapeutics 22
Ora Enters into Licensing Agreement with Nicox Ophthalmics 23
Fera Pharma Enters into Licensing Agreement with Nicox 24
Santen Extends Licensing Agreement with Eupharmed to Distribute Cationorm 25
NicOx Raises USD31 Million in Private Placement of Shares 26
Nicox to Raise USD20 Million in Private Placement of Shares 27
Nicox to Raise USD29.8 Million in Private Placement of Shares 28
Valeant Pharma Acquires Nicox for USD20 Million 29
NicOx Acquires Aciex Therapeutics 30
NicOx Acquires Doliage for USD6.5 Million 31
NicOx Completes Acquisition Of Eupharmed For US$8 Million 32
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 34
Akorn To Acquire Minority Stake In Aciex Therapeutics 36
NicOx SA, Key Competitors 37
NicOx SA, Key Employees 38
NicOx SA, Subsidiaries 39
List of Figures
NicOx SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
NicOx SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
NicOx SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
NicOx SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
NicOx SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
NicOx SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
NicOx SA, Medical Devices Deals, 2011 to YTD 2017 10
